These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Testing the safety of cultural viral vaccines]. Dobrotvortseva VG; Milovidova NI Vopr Virusol; 1981; (2):132-6. PubMed ID: 6168111 [No Abstract] [Full Text] [Related]
43. Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells. Gallagher RE; Gallo RC Science; 1975 Jan; 187(4174):350-3. PubMed ID: 46123 [TBL] [Abstract][Full Text] [Related]
44. Cultivation of dengue virus type 2 in candidate substrates for vaccine production. Dubois DR; Berman S; Rourke SM; Timchak RL; Lowenthal JP J Biol Stand; 1978 Jan; 6(1):21-6. PubMed ID: 415061 [No Abstract] [Full Text] [Related]
45. [Isolation of type C RNA-containing viruses from transplantable lines of human tissue]. Argirova RM; Zakharova LG; Al'shteĭn AD Vopr Virusol; 1973; 18(1):45-50. PubMed ID: 4134111 [No Abstract] [Full Text] [Related]
46. [Persistence of the Sindbis virus in cultures producing oncornavirus]. Pogodina VV; Fokina GI; Kiseleva LL; Graevskaia NA; Sito AF Vopr Virusol; 1978; (2):196-201. PubMed ID: 78589 [TBL] [Abstract][Full Text] [Related]
47. The laboratory control of viral vaccines. Perkins FT Prog Immunobiol Stand; 1967; 3():225-31. PubMed ID: 4985509 [No Abstract] [Full Text] [Related]
48. Preparation of vaccines--cell substrates. Perkins FT Adv Exp Med Biol; 1972; 31(0):187-96. PubMed ID: 4212264 [No Abstract] [Full Text] [Related]
50. Isolation of RNA virus from papillary tumors of the human renal pelvis. Elliott AY; Fraley EE; Cleveland P; Castro AE; Stein N Science; 1973 Jan; 179(4071):393-5. PubMed ID: 4118901 [TBL] [Abstract][Full Text] [Related]
51. Ensuring the safety of vaccine cell substrates by massively parallel sequencing of the transcriptome. Onions D; Côté C; Love B; Toms B; Koduri S; Armstrong A; Chang A; Kolman J Vaccine; 2011 Sep; 29(41):7117-21. PubMed ID: 21651935 [TBL] [Abstract][Full Text] [Related]
52. Quantitation in the evaluation of cell substrates for viral vaccine production. Parks WP; Hubbell ES Adv Exp Med Biol; 1979; 118():23-33. PubMed ID: 495268 [No Abstract] [Full Text] [Related]
53. ONg retroviral particles in chick cell grown vaccines. Weiss RA J Clin Virol; 1998 Jul; 11(1):3-6. PubMed ID: 9784138 [No Abstract] [Full Text] [Related]
54. [Use of a cocultivation method for detecting cytomegalovirus contamination of cell cultures of simian origin]. Karetnyĭ IuV; Dzagurov SG; Shalunova NV; Elekoev KA Vopr Virusol; 1982; 27(2):199-203. PubMed ID: 6283741 [TBL] [Abstract][Full Text] [Related]
55. The control of simian tissues used for human viral vaccine production. Magrath DI Prog Immunobiol Stand; 1967; 3():23-6. PubMed ID: 4985510 [No Abstract] [Full Text] [Related]
56. [Spontaneous contamination of primary green monkey kidney cell cultures by foamy virus]. Mironova LL; Preobrazhenskaia NK; Kniaginskaia IuG; Belova AG Vopr Virusol; 1980; (3):327-30. PubMed ID: 6254265 [TBL] [Abstract][Full Text] [Related]
58. Large-scale cultivation of cells in closed systems: stationary and moving. MacMorine HG; Laurence GD; Parisius W; Cucakovich NB Dev Biol Stand; 1976 Dec 13-15; 37():139-42. PubMed ID: 1031678 [TBL] [Abstract][Full Text] [Related]
59. Isolation and preliminary characterisation of a novel retrovirus isolated from a leukaemic dog. Safran N; Perk K; Eyal O; Dahlberg JE Res Vet Sci; 1992 Mar; 52(2):250-5. PubMed ID: 1374929 [TBL] [Abstract][Full Text] [Related]
60. The isolation of a 'non-cultivable' strain of Mycoplasma hyorhinis from a mammalian live virus vaccine. Woods SB J Biol Stand; 1983 Jul; 11(3):247-50. PubMed ID: 6885831 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]